Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30

$6.63−0.21 (-3.00%)

Close on Nov 13, 2026Market cap $102.42MP/E –Yield –

Satellos Bioscience r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $18.43M, up 28.3% from the year before.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$18.43M	+28.3%
FY2024	Dec 31, 2024	$14.36M	–

See a number that looks wrong?